Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 1,549,005 | 804,363 | 479,182 | 359,310 | 269,876 |
| Gross Profit | 1,549,005 | 804,363 | 479,182 | 359,310 | 269,876 |
| Operating Expenses | 581,854 | 408,927 | 260,545 | 155,130 | 113,425 |
| Operating Income | 967,152 | 395,436 | 218,637 | 204,180 | 156,451 |
| Interest Expense | 238,686 | 1,049 | 1,788 | 53,492 | 1,371 |
| Other Income | 176,027 | 34,177 | 38,487 | 10,891 | 12,870 |
| Pre-tax Income | 904,493 | 428,564 | 255,336 | 161,579 | 167,950 |
| Income Tax | 175,567 | 103,881 | 22,149 | -6,050 | -8,449 |
| Net Income Continuous | 728,926 | 324,683 | 233,187 | 167,629 | 176,399 |
| Net Income | $728,926 | $324,683 | $233,187 | $167,629 | $176,399 |
| EPS Basic Total Ops | 11.18 | 5.16 | 3.81 | 2.76 | 2.95 |
| EPS Basic Continuous Ops | 11.18 | 5.16 | 3.81 | 2.76 | 2.95 |
| EPS Diluted Total Ops | 11.06 | 5.10 | 3.76 | 2.70 | 2.86 |
| EPS Diluted Continuous Ops | 11.06 | 5.10 | 3.76 | 2.70 | 2.86 |
| EPS Diluted Before Non-Recurring Items | 11.18 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,006,830 | $416,272 | $218,637 | $204,180 | $156,451 |